Cam Gallagher - 06 Dec 2021 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Cam S. Gallagher
Issuer symbol
ZNTL
Transactions as of
06 Dec 2021
Net transactions value
-$713,300
Form type
4
Filing time
07 Dec 2021, 19:35:25 UTC
Previous filing
16 Nov 2021
Next filing
16 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale $713,300 -10,000 -2.3% $71.33 427,203 06 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 17, 2021.